PFF In The Media

NIH Awards Cedars-Sinai More Than $12 Million for Pulmonary Fibrosis Research

Investigators Aim to Uncover the Biological Processes Leading to Lung Damage After Viral Infections

Link to Article

More Than a Symptom: The Hidden Burden of Chronic Cough in ILD

“Cough has taken a part of my life away. Part of my dignity. My self-respect.” This is the reality for many patients living with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung diseases (non-IPF ILDs) who suffer from chronic cough.

Link to Article

Being a caregiver is hard, but resources are available to help make it easier

My wife became my full-time caregiver following my IPF diagnosis in 2017

Link to Article

ILD Day 2026: Educating healthcare professionals, patients about precision medicine

On Sept. 16, 13 organizations recognizing patients with different forms of interstitial lung disease will unite to celebrate the sixth annual ILD Day.

Link to Article

When a Cough Could Mean More

Shortness of breath, a chronic cough and fatigue can be easy to dismiss—but they may be signs of pulmonary fibrosis. 🫁 Dr. Amy Hajari Case of the Pulmonary Fibrosis Foundation explains why recognizing symptoms and getting an early, accurate diagnosis can make a difference.

Link to Article

Nintedanib dry powder inhalation therapy has favorable safety, tolerability in IPF

Nintedanib dry powder inhalation in patients with idiopathic pulmonary fibrosis was “generally safe” with “a tolerability profile built for chronic use,” according to topline data from a phase 1b study.

Link to Article

9 Tips to Calm Your IPF Cough

Most people with idiopathic pulmonary fibrosis (IPF) experience a chronic cough. It’s often the first symptom, and it may start years before you’re diagnosed. The cough is usually dry and unproductive, and it can be difficult to treat.

Link to Article

How to Manage Sudden Breathlessness With IPF

It can be very scary when you feel like you can’t breathe. You may feel like you’re running out of air or just can’t breathe deeply enough. Shortness of breath, called dyspnea, is a common symptom of idiopathic pulmonary fibrosis (IPF), a chronic condition in which lung tissue becomes thick and stiff.

Link to Article

Pulmonary Fibrosis Foundation adds 2 experts to help guide its future

The Pulmonary Fibrosis Foundation (PFF), an advocacy group dedicated to advancing care for people with pulmonary fibrosis, has added two new members to its board of directors.

Link to Article

Pulmonary fibrosis foundation adds two to board

Chicago pulmonologist Dr. Bradford Bemiss and Detroit pulmonary disease specialist Dr. Krishna Thavarajah have been named to the board of directors of the Pulmonary Fibrosis Foundation

Link to Article

Tech Can't Heal a Broken System: What Healthcare Leaders Want You to Know

As healthcare grows more digital, leaders across medicine, nursing, informatics, and patient advocacy are asking a more fundamental question: how can new technologies strengthen care rather than complicate it?

Link to Article

PFF Walk raises awareness about pulmonary fibrosis

Scott traveled from Arizona to Pittsburgh for a double lung transplant and watched Talk Pittsburgh while he was at the hospital. Now this weekend, Scott and his husband Carey will be walking to raise awareness and support for pulmonary fibrosis.

Link to Article

By working together, we will be able to have better therapies and a cure for PF

If you are a patient and not participating in research, I would like to ask you why.

Link to Article

How to Exercise With Idiopathic Pulmonary Fibrosis

When you have idiopathic pulmonary fibrosis (IPF), shortness of breath, chronic fatigue, and a nagging, dry cough can make exercise feel uncomfortable and even seem intimidating for some.

Link to Article

Travel Tips for Idiopathic Pulmonary Fibrosis

Traveling with idiopathic pulmonary fibrosis (IPF) may take extra planning, but it’s possible.

Link to Article

Inhaled treprostinil lowers FVC decline in IPF at 52 weeks

With receipt of inhaled treprostinil for 52 weeks, adults with idiopathic pulmonary fibrosis had less FVC decline compared with those receiving placebo, according to results published in The New England Journal of Medicine.

Link to Article

St. Luke’s designated as pulmonary center

St. Luke's University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation's nationally recognized Care Center Network, expanding access to specialized care for people living pulmonary fibrosis and interstitial lung disease in the region.

Link to Article

Pulmonary Fibrosis Foundation expands national care network, strengthening access to expert lung disease care

The Pulmonary Fibrosis Foundation’s Care Center Network has grown to include 96 sites in 40 states as part of its first expansion since 2023, marking a milestone in strengthening access to multidisciplinary care for people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).

Link to Article